What MYX chart shouts, page-361

Regurgitates is an appropriate word for your
saying nothing but repeating the graphs and
outlooks from Mayne leadership.
I will repeat from memory August 2019 they
signed agreement with Mithra to purchase
distribution rights USA . The outlook was
although this will be costing $500M + we
will have revenue of $200M within 4 years.
The simple facts it has cost us our Plant in
Nth Carolina. We have employed and trained
and continue to employ at huge expense 100
sales representatives across the US. With the
product being in the market place for 3 years plus
. Iurs $30m revenue atm is in anyone’s eyes a
dismal failure. Yet it is still being held up as this
saviour. Just do a quick analysis in comparison
to some Dermatology products. God man where
would we be without Derm.? Anyway the current
SP says it all not your repeating what our illustrious
executives are spruiking. Believe me man they are
taking care of themselves first and foremost.
That is why they don’t buy shares . Of course I
am frustrated I admit that because I once was a
fool just like you.